PHAXIAM Therapeutics SA (DELISTED) (PHXM:DL)
3.10
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
PHAXIAM Therapeutics 1 Year Total Returns (Daily)
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
March 11, 2024 | -58.95% |
March 08, 2024 | -60.76% |
March 07, 2024 | -61.66% |
March 06, 2024 | -62.38% |
March 05, 2024 | -65.98% |
March 04, 2024 | -71.75% |
March 01, 2024 | -64.43% |
February 29, 2024 | -67.80% |
February 28, 2024 | -67.80% |
February 27, 2024 | -64.83% |
February 26, 2024 | -59.05% |
February 23, 2024 | -67.72% |
February 22, 2024 | -66.84% |
February 21, 2024 | -67.47% |
February 20, 2024 | -58.61% |
February 16, 2024 | -58.05% |
February 15, 2024 | -58.00% |
February 14, 2024 | -57.87% |
February 13, 2024 | -55.89% |
February 12, 2024 | -53.12% |
February 09, 2024 | -58.00% |
February 08, 2024 | -59.70% |
February 07, 2024 | -62.36% |
February 06, 2024 | -65.04% |
February 05, 2024 | -66.50% |
Date | Value |
---|---|
February 02, 2024 | -68.55% |
February 01, 2024 | -69.57% |
January 31, 2024 | -53.23% |
January 30, 2024 | -41.67% |
January 29, 2024 | -25.55% |
January 26, 2024 | -19.02% |
January 25, 2024 | -18.72% |
January 24, 2024 | -9.81% |
January 23, 2024 | -16.86% |
January 22, 2024 | -14.50% |
January 19, 2024 | -15.48% |
January 18, 2024 | -14.55% |
January 17, 2024 | -1.91% |
January 16, 2024 | 4.85% |
January 12, 2024 | -3.58% |
January 11, 2024 | -8.30% |
January 10, 2024 | 12.69% |
January 09, 2024 | 9.52% |
January 08, 2024 | 35.36% |
January 05, 2024 | 40.96% |
January 04, 2024 | 41.94% |
January 03, 2024 | 52.65% |
January 02, 2024 | 45.41% |
December 29, 2023 | 34.50% |
December 28, 2023 | 41.77% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.01%
Minimum
Oct 03 2022
132.6%
Maximum
Dec 07 2020
-29.39%
Average
-38.63%
Median
Jul 09 2021
1 Year Total Returns (Daily) Benchmarks
DBV Technologies SA | -65.00% |
Cellectis SA | 78.14% |
Genfit SA | -13.02% |
Innate Pharma SA | -17.80% |
Inventiva SA | 26.10% |